Sara Pizzamiglio - Publications

Hypertension in Wilms Tumor at Diagnosis: Proposed Treatment Recommendations Starting From a Bi-Institutional Retrospective Observational Study.

Journal: Pediatric blood & cancer

Published: May 15, 2026

Harnessing cutting-edge techniques to identify novel gene expression signatures in acute myeloid leukemia patients.

Journal: Frontiers in bioinformatics

Published: February 06, 2026

Feasibility and activity of concurrent neoadjuvant chemotherapy and radiation therapy in patients with high-risk soft tissue sarcoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 05, 2026

Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas: A Secondary Analysis of a Randomized Clinical Trial.

Journal: JAMA network open

Published: November 06, 2025

HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapy.

Journal: NPJ breast cancer

Published: August 07, 2025

Reliability of core needle biopsy for HER2-low early-stage breast cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 03, 2024

From Real-World Data to Causally Interpretable Models: A Bayesian Network to Predict Cardiovascular Diseases in Adolescents and Young Adults with Breast Cancer.

Journal: Cancers

Published: September 13, 2024

Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial.

Journal: ESMO open

Published: June 26, 2024

Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 17, 2024

Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the Breast.

Journal: Clinical breast cancer

Published: December 22, 2023

Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO.

Journal: Breast cancer research and treatment

Published: November 09, 2023

A gene expression-based classifier for HER2-low breast cancer.

Journal: Scientific reports

Published: August 28, 2023